Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41
Related Experiment Video
Updated: Oct 15, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Y Taniguchi1, S Zolla-Pazner, Y Xu
1Laboratory of Virus Immunology, Kyoto University, Kyoto, 606-8507, Japan.
Abstract:
A mixture of two peptides from gp41 (N36 and C34) forms an alpha-helical structure that is thought to represent the fusogenic form of gp41. A human anti-gp41 monoclonal antibody (mAb 98-6), generated from the cells of an infected individual, reacted poorly with C34, but binding was strongly enhanced when N36 was added, indicating that the mAb reacts with a conformational epitope present in the fusogenic structure formed by the interaction of peptides N36 and C34. The epitope recognized by mAb 98-6 was found in lysates of virions on oligomeric forms of gp41 (dimers, trimers, and tetramers). On infected cells, the epitope was present as oligomers of gp41, as monomers of gp41, and as part of the envelope polyprotein gp160, obtained after biotinylation of intact cells, which were then lysed and immunoprecipitated with various mAbs. In lysates of infected cells, the epitope was present as part of both monomeric gp41 and gp160. These studies demonstrate that infected humans can respond to the fusogenic form of gp41 and that the anti-gp41 mAb studied here recognizes a conformational epitope formed by the interaction of two regions of gp41, which forms an alpha-helical bundle. This epitope is found on several forms of gp41 as it occurs in virions, on the surface of infected cells, and in infected cells.
Insights
Human antibodies can recognize the fusogenic form of gp41, a key viral protein. A specific monoclonal antibody (mAb 98-6) targets a conformational epitope on gp41 oligomers and polyproteins in virions and infected cells.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- The gp41 protein of HIV-1 plays a critical role in viral fusion.
- A specific alpha-helical structure formed by N36 and C34 peptides is believed to represent the fusogenic form of gp41.
Purpose of the Study:
- To characterize the epitope recognized by a human anti-gp41 monoclonal antibody (mAb 98-6).
- To determine the forms of gp41 and gp160 that present this epitope.
Main Methods:
- Peptide binding assays with N36 and C34.
- Immunoprecipitation of viral lysates and infected cell extracts.
- Biotinylation of intact infected cells followed by lysis and immunoprecipitation.
Main Results:
- mAb 98-6 binding to C34 was enhanced by N36, indicating recognition of a conformational epitope in the N36-C34 complex.
- The epitope was detected on oligomeric forms of gp41 (dimers, trimers, tetramers) in virions.
- The epitope was found on gp41 monomers, gp41 oligomers, and the gp160 polyprotein in infected cells.
Conclusions:
- Infected individuals can mount an immune response against the fusogenic form of gp41.
- mAb 98-6 recognizes a conformational epitope formed by the interaction of gp41 regions within an alpha-helical bundle.
- This epitope is present on multiple forms of gp41 and gp160 in virions and infected cells.
More Related Videos
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022